Healthcare provider profile · identity verified

John Terando, MD

Family Practice · FONTANA, CA · NPI 1346291598

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	173
Rosuvastatin Calcium	Rosuvastatin Calcium	261	97
Amlodipine Besylate	Amlodipine Besylate	235	83
Losartan Potassium	Losartan Potassium	229	80
Levothyroxine Sodium	Levothyroxine Sodium	228	72
Lisinopril	Lisinopril	198	74
Metformin Hcl Er	Metformin Hcl	158	55
Atenolol	Atenolol	140	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	15
Simvastatin	Simvastatin	111	39
Omeprazole	Omeprazole	108	46
Hydrochlorothiazide	Hydrochlorothiazide	98	37
Alendronate Sodium	Alendronate Sodium	95	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	28
Tamsulosin Hcl	Tamsulosin Hcl	82	30
Pradaxa	Dabigatran Etexilate Mesylate	81	23
Glipizide	Glipizide	73	29
Finasteride	Finasteride	72	27
Metformin Hcl	Metformin Hcl	66	25
Trazodone Hcl	Trazodone Hcl	64	24
Gabapentin	Gabapentin	63	19
Jardiance	Empagliflozin	63	24
Metoprolol Tartrate	Metoprolol Tartrate	63	21
Terazosin Hcl	Terazosin Hcl	63	20
Pantoprazole Sodium	Pantoprazole Sodium	58	24
Albuterol Sulfate Hfa	Albuterol Sulfate	56	29
Cefadroxil	Cefadroxil	53	52
Hydrocortisone	Hydrocortisone	51	21
Famotidine	Famotidine	47	22
Potassium Chloride	Potassium Chloride	46	18
Tramadol Hcl	Tramadol Hcl	46	11
Allopurinol	Allopurinol	45	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Meloxicam	Meloxicam	40	17
Ozempic	Semaglutide	40	suppressed
Spiriva Respimat	Tiotropium Bromide	40	14
Ezetimibe	Ezetimibe	39	13
Sertraline Hcl	Sertraline Hcl	39	17
Spironolactone	Spironolactone	37	11
Carvedilol	Carvedilol	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Clopidogrel	Clopidogrel Bisulfate	34	12
Colchicine	Colchicine	33	suppressed
Mirtazapine	Mirtazapine	31	12
Wixela Inhub	Fluticasone Propion/Salmeterol	31	11
Fluticasone Propionate	Fluticasone Propionate	29	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	26	26
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Alvesco	Ciclesonide	24	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Humulin N Kwikpen	Insulin Nph Human Isophane	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Amoxicillin	Amoxicillin	23	17
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	15
Furosemide	Furosemide	22	suppressed
Lorazepam	Lorazepam	20	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Metronidazole	Metronidazole	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Estradiol	Estradiol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Eliquis	Apixaban	16	suppressed
Erythromycin	Erythromycin Base	14	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error